Antibe Therapeutics Inc(Pre-Merger) T.ATE

Primary Symbol: ATBPF

Healthcare

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.

GREY:ATBPF - Post by User

Antibe Therapeutics Inc(Pre-Merger)

Bullboard Posts

Comment by mumfordsenon Mar 14, 2018 8:24pm

178 Views

Post# 27717189

RE:RE:RE:RE:RE:RE:RE:RE:Consolidating well, pop coming?

PoorOpinion wrote:

mumfordsen wrote: Just as many of us have predicted, a healthy consolidation which was why I said to walk away today unless you're looking to add to your position. Late tomorrow or Friday, I think we'll see 40+ cents. If no news on Monday, probably a small pullback as people think news is supposed to come out.

You're talking about the last 24-48 hrs as if you can draw some meaning for them for understanding the next 24-48 hrs. I call bs. If you you want to be in the stock before the announcement buy tomorrow,if you want to wait see what the data looks like then wait until next week. Thats your choice!

I already have a position. Go suck something.

Bullboard Posts

2024, a breakthrough year for silver